2019
DOI: 10.1111/jocd.12963
|View full text |Cite
|
Sign up to set email alerts
|

Successful treatment of facial vascular skin diseases with a 577‐nm pro‐yellow laser

Abstract: Background Treatment of vascular skin diseases is one of the most important indications of the laser. Aims To evaluate the effectiveness of 577‐nm pro‐yellow laser in the treatment of some vascular skin diseases. Patients/methods Ninety‐five patients with vascular skin diseases were included in this prospective monocentric study. They were classified into: port‐wine stain birthmarks (n = 37), papulopustular rosacea (n = 20), facial telangiectasia (n = 16), and facial erythema (n = 22). All participants receive… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
22
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(23 citation statements)
references
References 27 publications
1
22
0
Order By: Relevance
“…The short pulse time and specificity of the interaction between yellow light and hemoglobin permit this method to be applied without structural changes or scarring. 4 To the best of our knowledge, this is the first reported case of a 577-nm pro-yellow laser for the therapy of poikiloderma of Civatte.…”
Section: Successful Treatment Of Poikiloderma Of Civatte With a 577-nmentioning
confidence: 84%
“…The short pulse time and specificity of the interaction between yellow light and hemoglobin permit this method to be applied without structural changes or scarring. 4 To the best of our knowledge, this is the first reported case of a 577-nm pro-yellow laser for the therapy of poikiloderma of Civatte.…”
Section: Successful Treatment Of Poikiloderma Of Civatte With a 577-nmentioning
confidence: 84%
“…PWSs required longer sessions. They considered this laser safe for treating vascular lesions effectively (Mohamed, Mohamed Tawfik, & Hassan Ahmad, ).…”
Section: Discussionmentioning
confidence: 99%
“…15 The 577-nm yellow laser was introduced more than 20 years ago for the treatment of diabetic retinopathy, but has only been utilized in the field of dermatology in the past 2 years. 9,[16][17][18] This laser emits 100% yellow light, which allows it to specifically target oxyhemoglobin in vascular lesions, but with less absorption in melanin and a slightly deeper penetration into the dermis, thereby minimizing the risk of hyperpigmentation especially in patients with darker skin types. 9,15 The main chromophore for facial erythema is oxyhemoglobin which has three peak points-one at 418-nm, 542-nm and at 577-nm in visible light.…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, a study by Mohamed in 2019 looked into the effectiveness of the 577-nm laser not only for PWS birthmarks, but also for papulopustular rosacea, facial telangiectasia, and facial erythema, with the most success (63.6% of cases with excellent results) seen in the latter. 17 The setting used to treat rosacea and facial erythema patients ranged between F 12 and 16 J/cm 2 with pulse duration from 20 to 26 ms, and was done at 1-month intervals for a maximum of 5 sessions. In may be noted that in the above-mentioned study, the laser parameters used for facial erythema are quite similar to the range used in this study (F 10-16 J/cm 2 , 30 ms).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation